RGLS's logo.
Ticker Symbol: RGLS

Regulus Therapeutics Inc

$0.40 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001505512

Company Profile

Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 10628 Science Center Dr Ste 225
Website: regulusrx.com
CEO: Joseph Hagan
Tags:
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.37
Change: -$0.01 ( -0.73%)
Days Range: $1.28 - $1.39
Beta: 1.12
52wk. High: $2.14
52wk. Low: $0.76
Ytd. Change 0.00%
50 Day Moving Average: $1.42
200 Day Moving Average: $1.39
Shares Outstanding: 19484461

Valuation

Market Cap: 2.7B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A